Paroxysmal supraventricular tachycardia (PSVT)

Definition:
A rapid heart rate, which occurs from time to time (paroxysmal). PSVT starts by events taking place above the ventricles.

Alternative Names:
PSVT

Causes, incidence, and risk factors:

Normally, the chambers of the heart (atria and ventricles) contract in a coordinated manner. The contractions are caused by an electrical signal that begins in the sinoatrial node (also called the sinus node or SA node).

The signal is conducted through the atria (the upper heart chambers) and stimulates the atria to contract. The electrical signal then passes through the atrioventricular node (AV node), and travels through the ventricles (the larger, lower chambers), stimulating them to contract.

Paroxysmal supraventricular tachycardia (PSVT) can be initiated in the SA node; in the atria or the atrial conduction pathways; or in the AV node. It occurs most often in young people and infants.

Risks include excessive smoking, caffeine, and alcohol use. PSVT can occur with digitalis toxicity. It can be a form of a re-entry tachycardia (an electrical current is caught in a reentrant loop, excessively stimulating the heart), as in the case of Wolff-Parkinson-White syndrome.

Symptoms:
Additional symptoms that may be associated with this disease:

Note: Symptoms may start and stop suddenly, and can last for a few minutes or several hours. A PSVT that last for more than 50% of the day is considered a permanent or incessant PSVT.

Signs and tests:
An examination during a PSVT epsiode detects a regular, rapid heart rate. The heart rate may be 150 to 250 beats per minute (bpm) (in children the heart rate tends to be very high). There may be signs of poor perfusion (i.e., circulation) such as light-headedness. Between episodes of PSVT, the heart rate is normal (60 to 100 bpm).
  • An ECG during symptoms shows PSVT.
  • Because of the sporadic nature of the PSVT, its diagnosis may require continuous ambulatory monitoring. The most common is the 24-hour Holter monitoring. For longer recording periods, a "loop recorder" (with computer memory) is used.
  • An electrophysiologic test is often necessary for an accurate diagnosis, and to recommend the best treatment.
Treatment:

PSVT can occur with few or no symptoms, and may not require treatment. If symptoms occur or there are underlying cardiac disorders, treatment may be necessary.

People having an episode of PSVT can try to interrupt the episode with a Valsalva maneuver. This consists of holding the breath and straining (i.e., pushing with the abdomen as if to provoke a bowel movement) or coughing while sitting with the upper body bent forward. Splashing ice water on the face has been reported by some people as helpful.

Persons having an episode of PSVT may be offered therapy to interrupt the arrhythmia and convert it to a normal sinus rhythm. In the emergency room, a health care provider may massage the carotid arteries in the neck in an attempt to interrupt the arrhythmia. Caution -- do not try this at home! This technique can cause severe slowing of the heart rate.

Electrical cardioversion (shock) is successful in conversion of PSVT to a normal sinus rhythm in many cases. Another way to rapidly convert a PSVT is to administer intravenous medications, including adenosine and verapamil. Other medications may be used, such as esmolol, procainamide, beta-blockers, and propafenone.

Aside from treating isolated episodes of PSVT, some patients may require a long-term or definitive treatment of the PVST which is directed toward the prevention or complete erradication of further episodes or arrhythmia. Such long-term treatment includes:

  • Daily medications -- such as propafenone, flecainide, moricizine, sotalol, and amiodarone.
  • Radiofrequency catheter ablation -- a curative procedure introduced in the 1990's which is currently the treatment of choice for most PSVT's.
  • Surgical modification of the electrical conduction pathway (the pathways in the heart that conduct the impulse to contract) -- this may be recommended in some cases when other heart surgery for other reasons is also indicated.
  • Pacemakers -- very occasionally used in children with PSVT which hasn't responded to any other treatment. The pacemaker is designed to interrupt (override) the tachycardia.
Expectations (prognosis):
PSVT is generally not life-threatening, unless other cardiac disorders are present.
Complications:
Calling your health care provider:
  Call your health care provider if:
  • You often have a sensation of excessive palpitations and symptoms do not end spontaneously in a few minutes.
  • You have a history of PSVT and an episode does not resolve with Valsalva maneuver, or if other symptoms accompany the rapid heart rate.
  • Symptoms recur frequently, or new symptoms develop.
Prevention:
Avoid excessive smoking, caffeine, and alcohol use. Medications used to treat the disorder may be given as a preventive (prophylactic) treatment in people at a high risk or who have had previous episodes of PSVT.

Review Date: 5/3/2002
Reviewed By: Elena Sgarbossa, M.D., Department of Cardiology, Rush-Presbyterian St. Luke's Medical Ctr., Chicago, IL. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.